ArticleAnnals of clinical and translational neurology2019

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease.

Lee-Way Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.